Author

Angel Lanas

Epidemiological overview
Epidemiological overview

Angel Lanas

MANAGEMENT OF HELICOBACTER PYLORI INFECTION DURING THE LAST DECADE: TEMPORAL PRESCRIPTION TRENDS FOR THE FIRST-LINE OF NON-ALLERGIC PATIENTS AND ITS ADEQUACY TO CLINICAL GUIDELINES
MANAGEMENT OF HELICOBACTER PYLORI INFECTION DURING THE LAST DECADE: TEMPORAL PRESCRIPTION TRENDS FOR THE FIRST-LINE OF NON-ALLERGIC PATIENTS AND ITS ADEQUACY TO CLINICAL GUIDELINES

Angel Lanas  et al.

FIRST-LINE HELICOBACTER PYLORI ERADICATION RATE IN DAILY CLINICAL PRACTICE IN TWO SPANISH MEDICAL CENTERS: 2010-2019
FIRST-LINE HELICOBACTER PYLORI ERADICATION RATE IN DAILY CLINICAL PRACTICE IN TWO SPANISH MEDICAL CENTERS: 2010-2019

Angel Lanas  et al.

ERRORS IN EMPIRICAL ANTIBIOTIC THERAPIES FOR HELICOBACTER PYLORI ERADICATION IN 45,778 PATIENTS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ERRORS IN EMPIRICAL ANTIBIOTIC THERAPIES FOR HELICOBACTER PYLORI ERADICATION IN 45,778 PATIENTS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Angel Lanas  et al.

CHARACTERISTICS OF PATIENTS WITH HELICOBACTER PYLORI INFECTION WHO STOP CLINICAL SURVEILLANCE IN GASTROENTEROLOGY CLINICS
CHARACTERISTICS OF PATIENTS WITH HELICOBACTER PYLORI INFECTION WHO STOP CLINICAL SURVEILLANCE IN GASTROENTEROLOGY CLINICS

Angel Lanas  et al.

MISTAKES IN DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF HELICOBACTER PYLORI INFECTION IN THE LAST DECADE
MISTAKES IN DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF HELICOBACTER PYLORI INFECTION IN THE LAST DECADE

Angel Lanas  et al.

MANAGEMENT OF HELICOBACTER PYLORI INFECTION AT THE PRIMARY CARE LEVEL: EVALUATION OF DIFFERENT STRATEGIES TO IMPROVE ITS APPROACH
MANAGEMENT OF HELICOBACTER PYLORI INFECTION AT THE PRIMARY CARE LEVEL: EVALUATION OF DIFFERENT STRATEGIES TO IMPROVE ITS APPROACH

Angel Lanas  et al.

COLORECTAL CANCER PROGNOSIS AND DIAGNOSIS UTILITY OF A NEW NON INVASIVE INFLAMMATORY BLOOD BIOMARKER
COLORECTAL CANCER PROGNOSIS AND DIAGNOSIS UTILITY OF A NEW NON INVASIVE INFLAMMATORY BLOOD BIOMARKER

Angel Lanas  et al.

EVIDENCE-BASED SELECTION ON THE APPROPRIATE FIT CUT-OFF POINT IN CRC SCREENING PROGRAMS IN THE COVID PANDEMIC
EVIDENCE-BASED SELECTION ON THE APPROPRIATE FIT CUT-OFF POINT IN CRC SCREENING PROGRAMS IN THE COVID PANDEMIC

Angel Lanas  et al.

EVALUATION OF THE ACCURACY OF THE "LIAISON(R) MERIDIAN HELICOBACTER PYLORI SA" STOOL ANTIGEN TEST FOR THE DIAGNOSIS OF H. PYLORI INFECTION: A SPANISH MULTICENTRE STUDY
EVALUATION OF THE ACCURACY OF THE "LIAISON(R) MERIDIAN HELICOBACTER PYLORI SA" STOOL ANTIGEN TEST FOR THE DIAGNOSIS OF H. PYLORI INFECTION: A SPANISH MULTICENTRE STUDY

Angel Lanas  et al.

REPEATING FAECAL IMMUNOCHEMICAL TEST FOR HAEMOGLOBIN IS A USEFUL STRATEGY TO AVOID NORMAL COLONOSCOPIES IN COLORECTAL CANCER SCREENING
REPEATING FAECAL IMMUNOCHEMICAL TEST FOR HAEMOGLOBIN IS A USEFUL STRATEGY TO AVOID NORMAL COLONOSCOPIES IN COLORECTAL CANCER SCREENING

Angel Lanas  et al.

FALSE POSITIVES IN FECAL IMMUNOCHEMICAL TEST IN COLORECTAL CANCER SCREENING AND THE RELATION WITH HARMFUL GASTROINTESTINAL DRUGS: THE IMPORTANCE OF THE EFFECT OF COMBINING PPI AND GASTROINTESTINAL DAMAGING DRUGS
FALSE POSITIVES IN FECAL IMMUNOCHEMICAL TEST IN COLORECTAL CANCER SCREENING AND THE RELATION WITH HARMFUL GASTROINTESTINAL DRUGS: THE IMPORTANCE OF THE EFFECT OF COMBINING PPI AND GASTROINTESTINAL DAMAGING DRUGS

Angel Lanas  et al.

EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 8,000 PATIENTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 8,000 PATIENTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

Angel Lanas  et al.

EFFECTIVENESS OF SECOND-LINE HELICOBACTER PYLORI ERADICATION TREATMENTS IN SPAIN: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EFFECTIVENESS OF SECOND-LINE HELICOBACTER PYLORI ERADICATION TREATMENTS IN SPAIN: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Angel Lanas  et al.

ASSESSMENT OF THE FECAL IMMUNOCHEMICAL TEST CUTOFF LEVEL IN SCREENING POPULATION DEPENDING ON GENDER
ASSESSMENT OF THE FECAL IMMUNOCHEMICAL TEST CUTOFF LEVEL IN SCREENING POPULATION DEPENDING ON GENDER

Angel Lanas  et al.

THERMAL LIQUID BIOPSY PROFILES FROM PANCREATIC CANCER PLASMA SAMPLES CLUSTERED ACCORDING TO DIAGNOSIS AND PROGNOSIS CLINICAL DATA
THERMAL LIQUID BIOPSY PROFILES FROM PANCREATIC CANCER PLASMA SAMPLES CLUSTERED ACCORDING TO DIAGNOSIS AND PROGNOSIS CLINICAL DATA

Angel Lanas  et al.

COMPARISON OF THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION REGIMENS BETWEEN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
COMPARISON OF THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION REGIMENS BETWEEN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Angel Lanas  et al.

ROLE OF PROTON PUMP INHIBITORS DOSAGE IN THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ROLE OF PROTON PUMP INHIBITORS DOSAGE IN THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Angel Lanas  et al.

DIFFERENCES OF HELICOBACTER PYLORI DIAGNOSTICS AND TREATMENTS IN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
DIFFERENCES OF HELICOBACTER PYLORI DIAGNOSTICS AND TREATMENTS IN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Angel Lanas  et al.

EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2021: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EMPIRICAL FIRST-LINE TREATMENT USE AND EFFECTIVENESS TRENDS IN EUROPE IN THE PERIOD 2013-2021: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Angel Lanas  et al.

Item 1 - 20 / 33
1
2